[go: up one dir, main page]

AU4924199A - Repressor proteins producing cell lines for the propagation of vectors - Google Patents

Repressor proteins producing cell lines for the propagation of vectors

Info

Publication number
AU4924199A
AU4924199A AU49241/99A AU4924199A AU4924199A AU 4924199 A AU4924199 A AU 4924199A AU 49241/99 A AU49241/99 A AU 49241/99A AU 4924199 A AU4924199 A AU 4924199A AU 4924199 A AU4924199 A AU 4924199A
Authority
AU
Australia
Prior art keywords
vectors
propagation
cell lines
producing cell
repressor proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49241/99A
Inventor
Frank L Graham
David Alan Matthews
Ludvik Prevec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advec Inc
Original Assignee
Advec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advec Inc filed Critical Advec Inc
Publication of AU4924199A publication Critical patent/AU4924199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10344—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU49241/99A 1998-07-30 1999-07-30 Repressor proteins producing cell lines for the propagation of vectors Abandoned AU4924199A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9468198P 1998-07-30 1998-07-30
US60094681 1998-07-30
US22382098A 1998-12-31 1998-12-31
US09223820 1998-12-31
PCT/IB1999/001349 WO2000006751A2 (en) 1998-07-30 1999-07-30 Repressor proteins producing cell lines for the propagation of vectors

Publications (1)

Publication Number Publication Date
AU4924199A true AU4924199A (en) 2000-02-21

Family

ID=26789139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49241/99A Abandoned AU4924199A (en) 1998-07-30 1999-07-30 Repressor proteins producing cell lines for the propagation of vectors

Country Status (2)

Country Link
AU (1) AU4924199A (en)
WO (1) WO2000006751A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080044378A1 (en) * 2006-05-15 2008-02-21 Introgen Therapeutics, Inc. Methods and Compositions for Protein Production Using Adenoviral Vectors
GB201322798D0 (en) * 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
CN111433356B (en) * 2017-10-10 2023-12-19 南特生物科学公司 Modified EC7 cells with low toxicity to viral production payloads
EP4058067A1 (en) * 2019-11-12 2022-09-21 Oxford BioMedica (UK) Limited Production system
WO2025153852A1 (en) * 2024-01-17 2025-07-24 1. Revvity Gene Delivery Gmbh Production of viral vectors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7081896A (en) * 1995-10-05 1997-04-28 Microbix Biosystems Inc. Rabies recombinant adenovirus
US5972650A (en) * 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch

Also Published As

Publication number Publication date
WO2000006751A3 (en) 2000-05-04
WO2000006751A2 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
AU1340000A (en) Novel adenoviral vector and methods for making and using the same
AU6968398A (en) Process for producing low density gel compositions
AU4544396A (en) Cells for the production of recombinant adenoviruses
AU6330099A (en) Novel heterocyclyl-methyl-substituted pyrazoles
HUP0001941A3 (en) Methods for production of hybrid wheat
AU5134599A (en) Expression of functional eukaryotic proteins
AU6330199A (en) Electrochemical synthesis of perfluoroalkylfluorophosphoranes
AU7112798A (en) Process for producing low density gel compositions
AU2373800A (en) Neuron-associated proteins
AU2445601A (en) Mammalian protein phosphatases
AU8267998A (en) High density streptavidin supports
AU5315796A (en) Mammalian expression vectors
AU4208897A (en) Oligocistronic expression system for the production of heteromeric proteins
AU7962398A (en) Mammalian genes; related reagents
AU4077099A (en) Cell signaling proteins
AU4099699A (en) Improved vectors
AU5504999A (en) Production of proteins
AU4924199A (en) Repressor proteins producing cell lines for the propagation of vectors
AU7709000A (en) Methods for producing recombinant proteins
AU2946399A (en) Mammalian sodium channel proteins
IL143052A0 (en) Mammalian chondromodulin-like protein
AU2869300A (en) Fiber receptor-independent system for the propagation of adenoviral vectors
AU2071799A (en) Placental protein 13
AU7146698A (en) Method of determining three-dimensional protein structure from primary protein sequence
AU2061201A (en) Mammalian dishevelled-associated proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase